ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $1.15, $0.10 better than the analyst estimate of $1.05. Revenue for the quarter came in at $96.7 million versus the consensus estimate of $89.66 million.

GUIDANCE:

ICU Medical sees FY2016 EPS of $4.45-$4.60, versus the consensus of $4.43. ICU Medical sees FY2016 revenue of $360-370 million, versus the consensus of $362.24 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.